DYRK1A and hepatocellular carcinoma: In mouse, we also found that targeting DYRK1 could minish tumor growth for HCC cells with high expression of TROAP. Therefore, on the bases of previous studies, we clearly revealed the secrets of TROAP in promotion of HCC progression and preliminarily explored its therapeutic potential in HCC.